BRCHF BRAINCHIP HLDGS LTD ORD

BrainChip Holdings Ltd develops software and hardware accelerated solutions for artificial intelligence (AI) and machine learning applications in North America, Europe, the Middle East, and Asia. It offers Akida Development Environment, a machine learning framework for creating, training, and testing neural networks, as well as supporting the development of systems for edge AI on its Akida event domain neural processor; and Akida Neuromorphic Processor to provide a ultra-low power and fast AI Edge Network for vision, audio, olfactory, and smart transducer applications. The company also provides Akida Neuromorphic System-on-Chip, an integrated solution for Edge AI device and systems. Its products are used in various applications, such as automotive and cybersecurity. The company has a research collaboration with Biotome Pty Ltd for SARS-CoV-2 antibody detection. BrainChip Holdings Ltd was incorporated in 2011 and is based in Sydney, Australia.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.62    OTCQX
As of 07/01/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Unknown
Industry:  
Index country:  Australia
Country of incorporation:  
IPO date:  08/11/2021
Outstanding shares:  1,719,362,144
Average volume:  70,137
Market cap:   $1,066,004,529
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy